Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Type of study
Publication year range
1.
Aviakosm Ekolog Med ; 44(1): 15-20, 2010.
Article in Russian | MEDLINE | ID: mdl-20803992

ABSTRACT

Experiments with 120 mongrel dogs were aimed at the assessment of radio protective strength of indralin and local shielding of the pelvic marrow from 2.5 Gy, and also their concurrent use for the dogs irradiated by protons (240 MeV) at absolutely lethal and over-lethal 4 Gy and 5 Gy. Clinical observations, hematological investigations and ECG analysis of survived animals were conducted 4.5 years post the irradiation. Dogs that remained healthy following 3.5 to 4.5 years since the irradiation were sacrificed for pathomorphological investigations. The radioprotective effect of local shielding against 4 Gy was weak while this effect of intramuscular indralin (10, 20, 40 mg/kg of body) was significant reaching 50 to 67.7%. The concurrent use of two methods had, apparently, potentiated the 100% radioprotection of the animals irradiated by overlethal 5 Gy. Blood investigations of the survived dogs every 2-4 months evidenced that complete recovery of the total leukocyte count had taken 9 to 13 months. Also, dogs' pregnancy in 9-10 months since the beginning of irradiation pointed to maintenance of fertility and the ability to parturiate 2 or 3 times yielding 5-6 live cubs. Necropsy of the dogs did not reveal gross macroscopic structural changes of visceral organs or tissues. Seven out of 27 sacrificed dogs had benign tumors infrequent in intact dogs at this age.


Subject(s)
Phenols/administration & dosage , Protons/adverse effects , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/administration & dosage , Animals , Bone Marrow/drug effects , Bone Marrow/pathology , Bone Marrow/radiation effects , Dogs , Dose-Response Relationship, Radiation , Female , Gamma Rays , Hematopoiesis/drug effects , Hematopoiesis/radiation effects , Leukocyte Count , Male , Radiation Injuries, Experimental/pathology
2.
Aviakosm Ekolog Med ; 29(5): 42-6, 1995.
Article in Russian | MEDLINE | ID: mdl-8664875

ABSTRACT

During interplanetary missions ionizing radiations blended with other debilitating non-radiation environmental agents which can modify the radiobiological effect make up a risk factor. Still, the experimental data about the direction of the modifying action are conflicting and diverge from an increase to a depression of radioresistance. In this work we investigated the influence of prolonged hypokinesia on early radiobiological effects. The experiment was conducted with Wistar rats exposed to acute gamma-radiation at a dose of 7.5 Gy after 25 days of head-down immobilization. In the period of one month since exposure the morphological properties of peripheral blood and bone marrow, cell composition and mass of thymus, spleen and adrenal masses have been investigated. A significant, 1.5-2-fold, inhibition of recovery rate was displayed by each sprout of the blood-forming and especially thymolymphatic systems (2.5-3 folds) resulting from combined stress, whereas the depth of radiation damage in terms of maximum degree of the bone marrow tissue depopulation, cytopenia of peripheral blood and mass losses of lymphoid organs was of little difference in the two groups.


Subject(s)
Aerospace Medicine , Hematopoietic System/physiology , Hypokinesia , Lymphoid Tissue/physiology , Radiation, Ionizing , Adrenal Glands/physiology , Adrenal Glands/radiation effects , Animals , Bone Marrow/physiology , Bone Marrow/radiation effects , Female , Hematopoietic System/radiation effects , Immobilization , Lymphoid Tissue/radiation effects , Radiation Dosage , Rats , Rats, Wistar , Spleen/physiology , Spleen/radiation effects , Thymus Gland/physiology , Thymus Gland/radiation effects , Time Factors
3.
Aviakosm Ekolog Med ; 26(3): 35-7, 1992.
Article in Russian | MEDLINE | ID: mdl-1297488

ABSTRACT

The methodology of clinical testing of antiradiation measures to be used in manned space missions is proposed and discussed. The tests should be based on: an individual tolerance to a recommended medicinal form of the drug; the tolerances to the effects of motion sickness, prolonged transverse and longitudinal accelerations; graded physical exercise; evaluation of performance (operator activity).


Subject(s)
Clinical Trials as Topic/methods , Radiation-Protective Agents/therapeutic use , Space Flight , Drug Tolerance , Gravitation , Humans , Radiation-Protective Agents/adverse effects , Time Factors , Vestibule, Labyrinth/drug effects
4.
Med Radiol (Mosk) ; 35(2): 33-5, 1990 Feb.
Article in Russian | MEDLINE | ID: mdl-2156123

ABSTRACT

Electrocardiography was used to analyze the results of 4-year investigations of the cardiac activity and reactivity (adrenalin test) in 32 dogs irradiated with high-energy protons (approximately 240 MeV) at absolutely lethal doses of 4 and 5 Gy. The author's and literature data have shown the similarity of cardiac functional features and reactivity in a long-term period in dogs with those in animals after radiation disease caused by exposure to some other types of ionizing radiations.


Subject(s)
Heart/radiation effects , Protons , Acute Disease , Animals , Dogs , Dose-Response Relationship, Radiation , Electrocardiography/drug effects , Electrocardiography/radiation effects , Epinephrine , Heart/drug effects , Heart/physiopathology , Heart Rate/drug effects , Heart Rate/physiology , Heart Rate/radiation effects , Radiation Injuries, Experimental/physiopathology , Time Factors , Whole-Body Irradiation
5.
Kosm Biol Aviakosm Med ; 17(6): 10-7, 1983.
Article in Russian | MEDLINE | ID: mdl-6418950

ABSTRACT

This paper reviews existing data on bone marrow partial shielding in animal studies with reference to partial-body protection in space radiobiology and medicine. Analysis of reported data indicates the efficacy of the method to protect animals (including dogs) exposed to gamma-radiation and high-energy protons. Experimental findings that demonstrate the effectiveness of bone marrow partial shielding show that this method may be used for partial-body protection in space flight.


Subject(s)
Bone Marrow/radiation effects , Cosmic Radiation , Radiation Protection/methods , Space Flight , Animals , Bone Marrow Transplantation , Dogs , Gamma Rays , Haplorhini , Humans , Mice , Radiation Dosage , Radiation Injuries, Experimental/prevention & control , Rats , Whole-Body Irradiation
6.
Kosm Biol Aviakosm Med ; 17(3): 4-8, 1983.
Article in Russian | MEDLINE | ID: mdl-6308339

ABSTRACT

This paper summarizes studies of the combined protection of dogs exposed to acute high energy proton irradiation at a dose of 400 rad. The chemical radioprotector--mexamine--was injected intramuscularly at a dose of 10 mg/kg or administered per os at a dose of 75 mg/kg. During the exposure 14.5% of bone marrow was shielded. The dose behind the shielding was 250 rad. The combined use of mexamine administered per os and partial bone marrow shielding provided better protection, whereas either type of protection applied separately proved inefficient.


Subject(s)
Radiation Protection/methods , Space Flight , 5-Methoxytryptamine/administration & dosage , Animals , Dogs , Female , Leukocyte Count , Male , Protons , Radiation Dosage , Radiation Injuries, Experimental/epidemiology , Radiation Injuries, Experimental/mortality , Radiation Protection/instrumentation , Radiation-Protective Agents/administration & dosage , Space Flight/instrumentation , Time Factors
9.
Kosm Biol Aviakosm Med ; 15(1): 3-9, 1981.
Article in Russian | MEDLINE | ID: mdl-6261037

ABSTRACT

Comparison of chemical protection against electromagnetic radiations (X- and gamma-rays) and high-energy proton radiations give evidence that the mechanism of antiradiation effects of radioprotectors and other biological protectors against different radiations is identical. On the basis of the data published in the literature it has been shown that the degree of radiation protection of animals and other biological objects in comparable doses differs insignificantly during exposures to proton and standard irradiations.


Subject(s)
Protons , Radiation Injuries, Experimental/prevention & control , Radiation-Protective Agents/therapeutic use , 5-Methoxytryptamine/therapeutic use , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/therapeutic use , Amino Acids/therapeutic use , Animals , Cornea/radiation effects , Dogs , Female , Gamma Rays , Haplorhini , Hematopoietic System/radiation effects , Hydroxylamines/therapeutic use , Male , Mercaptoethylamines/therapeutic use , Mice , Neoplasms, Radiation-Induced/prevention & control , Prodigiozan/therapeutic use , Propiophenones/therapeutic use , Radiation , Rats , Space Flight , Vitamins/therapeutic use , X-Rays , Yeasts/radiation effects , beta-Aminoethyl Isothiourea/analogs & derivatives , beta-Aminoethyl Isothiourea/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...